Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_provenance.
- NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_assertion description "[Targeted testing for these three mutations (BRCA1 187delAG, BRCA1 5385insC, and BRCA2 6174delT) is therefore recommended for all AJ breast and ovarian cancer patients, regardless of age of diagnosis or family history.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_provenance.
- NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_assertion evidence source_evidence_literature NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_provenance.
- NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_assertion SIO_000772 25476495 NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_provenance.
- NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_assertion wasDerivedFrom befree-2016 NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_provenance.
- NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_assertion wasGeneratedBy ECO_0000203 NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_provenance.
- befree-2016 importedOn "2016-02-19" NP1244942.RAt5wYF-hw3DfZni3H-w9L41Tgn4pKnex3Yiib-tM08xw130_provenance.